Track the 진바이오텍 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Food & Beverage sector, 진바이오텍 has recorded 12 public disclosures. Market capitalisation: €34.1bn. The latest transaction was disclosed on 15 May 2026 (Purchase). Among the most active insiders: 김성호. All data is accessible without an account.
12
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,161 of 26,212 companies
57.5
score / 100
Value
78
Quality
37
FCF yld9.7%
Earn yld9.5%
EV/EBITDA8.6x
ROE·
Gross mgn16%
Net mgn4.2%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.